Pulse Biosciences, Inc.’s $15 Million Rights Offering

BakerHostetler represented Pulse Biosciences in its public rights offering. Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Sonia Carcano

Author: Sonia Carcano

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here